New developments in pediatric plastic surgery research

Clinics in Plastic Surgery

Volumn 32, Issue 1, 2005, Pages 123-136

  Nacamuli, Randall P ^a   Wan, Derrick C ^a   Lenton, Kelly A ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; COLLAGEN; FIBROBLAST GROWTH FACTOR RECEPTOR; HYALURONIC ACID; NOGGIN;

ADOPTIVE IMMUNOTHERAPY; BONE DEVELOPMENT; BONE TISSUE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DIAGNOSTIC PROCEDURE; GENETIC COUNSELING; HUMAN; MOLECULAR GENETICS; NONHUMAN; PEDIATRIC SURGERY; PLASTIC SURGERY; REVIEW; TISSUE ENGINEERING; ANIMAL; CHILD; DISTRACTION OSTEOGENESIS; MEDICAL RESEARCH; PHYSIOLOGY;

ANIMALS; BIOMEDICAL RESEARCH; CHILD; CRANIAL SUTURES; HUMANS; OSTEOGENESIS, DISTRACTION; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE ENGINEERING;

EID: 14744293113     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2004.10.003     Document Type: Review

References (152)

1. Moss ML. Fusion of the frontal suture in the rat. Am J Anat 1958;102:141-66.
2. Waterston RH, Lindblad-Toh K, Birney E, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-62.
3. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM. Tissue origins and interactions in the mammalian skull vault. Dev Biol 2002;241:106-16.
4. Noden DM. Craniofacial development: new views on old problems. Anat Rec 1984;208:1-13.
5. Couly GF, Coltey PM, Le Douarin NM. The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 1993;117:409-29.
6. Ferreira JC, Carter SM, Bernstein PS, et al. Second-trimester molecular prenatal diagnosis of sporadic apert syndrome following suspicious ultrasound findings. Ultrasound Obstet Gynecol 1999;14:426-30.
7. Cassileth LB, Bartlett SP, Glat PM, et al. Clinical characteristics of patients with unicoronal synostosis and mutations of fibroblast growth factor receptor 3: a preliminary report. Plast Reconstr Surg 2001;108: 1849-54.
8. von Gernet S, Golla A, Ehrenfels Y, et al. Genotype-phenotype analysis in apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. Clin Genet 2000;57:137-9.
9. Wilkie AO. Craniosynostosis: genes and mechanisms. Hum Mol Genet 1997;6:1647-56.
10. Mehrara BJ, Mackool RJ, McCarthy JG, et al. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg 1998;102: 1805-17.
11. Greenwald JA, Mehrara BJ, Spector JA, et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency. J Bone Miner Res 2000; 15:2413-30.
12. Greenwald JA, Mehrara BJ, Spector JA, et al. In vivo modulation of fgf biological activity alters cranial suture fate. Am J Pathol 2001;158:441-52.
13. Iseki S, Wilkie AO, Morriss-Kay GM. Fgfr1 and fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 1999;126:5611-20.
14. Iseki S, Wilkie AO, Heath JK, et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied fgf2. Development 1997;124:3375-84.
15. Song HM, Nacamuli RP, Xia W, et al. High-dose retinoic acid modulates rat calvarial osteoblast biology. J Cell Phys 2005;202(1):255-62.
16. Ignelzi Jr MA, Wang W, Young AT. Fibroblast growth factors lead to increased msx2 expression and fusion in calvarial sutures. J Bone Miner Res 2003;18:751-9.
17. Wilkie AOM, Tang Z, Blanko N, et al. Functional haploinsufficiency of the human homeobox gene msx2 causes defects in skull ossification. Nat Genet 2000;24:387-90.
18. Jabs EW, Muller U, Li X, et al. A mutation in the homeodomain of the human msx2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75:443-50.
19. Kim HJ, Rice DP, Kettunen PJ, et al. Fgf-, bmp- and shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998;125:1241-51.
20. Liu YH, Tang Z, Kundu RK, et al. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for msx2-mediated craniosynostosis in humans. Dev Biol 1999;205: 260-74.
21. Satokata I, Ma L, Ohshima H, et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 2000;24: 391-5.
22. Ishii M, Merrill AE, Chan YS, et al. Msx2 and twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 2003;130:6131-42.
23. Chen ZF, Behringer RR. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995;9:686-99.
24. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, et al. Mutations of the twist gene in the saethre-chotzen syndrome. Nat Genet 1997;15:42-6.
25. Howard TD, Paznekas WA, Green ED, et al. Mutations in twist, a basic helix-loop-helix transcription factor, in saethre-chotzen syndrome. Nat Genet 1997; 15:36-41.
26. Gripp KW, Zackai EH, Stolle CA. Mutations in the human twist gene. Hum Mutat 2000;15:150-5.
27. Carver EA, Oram KF, Gridley T. Craniosynostosis in twist heterozygous mice: a model for saethre- chotzen syndrome. Anat Rec 2002;268:90-2.
28. Rice DP, Aberg T, Chan Y, et al. Integration of fgf and twist in calvarial bone and suture development. Development 2000;127:1845-55.
29. Johnson D, Iseki S, Wilkie AO, et al. Expression patterns of twist and fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. Mech Dev 2000;91: 341-5.
30. Bialek P, Kern B, Yang X, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004;6:423-35.
31. McMahon JA, Takada S, Zimmerman LB, et al. Noggin-mediated antagonism of bmp signaling is required for growth and patterning of the neural tube and somite. Genes Dev 1998;12:1438-52.
32. Warren SM, Brunet LJ, Harland RM, et al. The bmp antagonist noggin regulates cranial suture fusion. Nature 2003;422:625-9.
33. Nacamuli RP, Fong KD, Warren SM, et al. Markers of osteoblast differentiation in fusing and nonfusing cranial sutures. Plast Reconstr Surg 2003;112: 1328-35.
34. Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 2001;27:84-8.
35. Nacamuli RP, Fong KD, Lenton KA, et al. Expression and possible mechanisms of regulation of bmp3 in rat cranial sutures. Plas Recon Surg, Accepted for publication.
36. Lemonnier J, Hay E, Delannoy P, et al. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase c and interleukin-1. Am J Pathol 2001;158:1833-42.
37. Dry GM, Yasinskaya YI, Williams JK, et al. Inhibition of apoptosis: a potential mechanism for syndromic craniosynostosis. Plast Reconstr Surg 2001; 107:425-32.
38. Furtwangler JA, Hall SH, Koskinen-Moffett LK. Sutural morphogenesis in the mouse calvaria: the role of apoptosis. Acta Anat (Basel) 1985;124:74-80.
39. Opperman LA, Adab K, Gakunga PT. Transforming growth factor-beta 2 and tgf-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 2000;219: 237-47.
40. Agresti M, Schaefer RB, Recinos RF, et al. Detection of apoptosis in normal postantal mouse cranial sutures. Las Vegas (NV): Plastic Surgery Research Council; 2003.
41. Zhang X, Carpenter D, Bokui N, et al. Overexpression of nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J Bone Miner Res 2003;18:2126-34.
42. Fong KD, Song HM, Nacamuli RP, et al. Apoptosis in a rodent model of cranial suture fusion: in situ imaging and gene expression analysis. Plast Reconstr Surg 2004;113:2037-47.
43. McCarthy JG, Schreiber J, Karp N, et al. Lengthening the human mandible by gradual distraction. Plast Reconstr Surg 1992;89:1-8.
44. Ilizarov GA, Ledyaev VI. The replacement of long tubular bone defects by lengthening distraction osteotomy of one of the fragments. 1969. Clin Orthop 1992;7-10.
45. Ilizarov G. Clinical application of the tension-stress effect for limb lengthening. Clin Orthop 1990;8-26.
46. McCarthy J. The role of distraction osteogenesis in the reconstruction of the mandible in unilateral craniofacial microsomia. Clin Plast Surg 1994;21: 625-31.
47. Gosain AK. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg 2001;107: 278-80.
48. Cohen SR, Burstein FD, Williams JK. The role of distraction osteogenesis in the management of craniofacial disorders. Ann Acad Med Singapore 1999; 28:728-38.
49. Aronson J. Experimental and clinical experience with distraction osteogenesis. Cleft Palate Craniofac J 1994;31:473-81.
50. Karaharju-Suvanto T, Karaharju EO, Ranta R. Mandibular distraction. An experimental study on sheep. J Craniomaxillofac Surg 1990;18:280-3.
51. Califano L, Cortese A, Zupi A, et al. Mandibular lengthening by external distraction: an experimental study in the rabbit. J Oral Maxillofac Surg 1994;52: 1179-83.
52. Sato M, Ochi T, Nakase T, et al. Mechanical tension-stress induces expression of bone morphogenetic protein (bmp)-2 and bmp-4, but not bmp-6, bmp-7, and gdf-5 mrna, during distraction osteogenesis. J Bone Miner Res 1999;14:1084-95.
53. Mehrara BJ, Rowe NM, Steinbrech DS, et al. Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast Reconstr Surg 1999;103:536-47.
54. Ashinoff RL, Cetrulo Jr CL, Galiano RD, et al. Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis. Ann Plast Surg 2004;52: 585-90.
55. Tong L, Buchman SR, Ignelzi Jr MA, et al. Focal adhesion kinase expression during mandibular distraction osteogenesis: evidence for mechanotransduction. Plast Reconstr Surg 2003;111:211-22.
56. Fang TD, Nacamuli RP, Song HM, et al. Creation and characterization of a mouse model of mandibular distraction osteogenesis. Bone 2004;34:1004-12.
57. Prendergast PJ. Finite element models in tissue mechanics and orthopaedic implant design. Clin Biomech (Bristol, Avon) 1997;12:343-66.
58. Carter DR, Beaupre GS, Giori NJ, et al. Mechanobiology of skeletal regeneration. Clin Orthop 1998: S41-55.
59. van der Meulen MC, Huiskes R. Why mechanobiology? A survey article. J Biomech 2002;35:401-14.
60. Carter DR, Blenman PR, Beaupre GS. Correlations between mechanical stress history and tissue differentiation in initial fracture healing. J Orthop Res 1988;6:736-48.
61. Loboa EG, Beaupre GS, Carter DR. Mechanobiology of initial pseudarthrosis formation with oblique fractures. J Orthop Res 2001;19:1067-72.
62. Loboa EG, Fang TD, Warren SM, et al. Mechanobiology of mandibular distraction osteogenesis: Experimental analyses with a rat model. Bone 2004;34: 336-43.
63. Loboa E, Fang TD, Parker DW, et al. Mechanobiology of mandibular distraction osteogenesis-finite element analyses with a rat model. J Orthop Res, Accepted for publication.
64. Ortiz Monasterio F, Molina F, Andrade L, et al. Simultaneous mandibular and maxillary distraction in hemifacial microsomia in adults: avoiding occlusal disasters. Plast Reconstr Surg 1997;100:852-61.
65. Mofid MM, Manson PN, Robertson BC, et al. Craniofacial distraction osteogenesis: a review of 3278 cases. Plast Reconstr Surg 2001;108:1103-14.
66. Cho BC, Park JW, Baik BS, et al. Clinical application of injectable calcium sulfate on early bony consolidation in distraction osteogenesis for the treatment of craniofacial microsomia. J Craniofac Surg 2002;13: 465-75.
67. De Bastiani G, Aldegheri R, Renzi-Brivio L, et al. Limb lengthening by callus distraction (callotasis). J Pediatr Orthop 1987;7:129-34.
68. Lazo-Zbikowski J, Aguilar F, Mozo F, et al. Biocompression external fixation. Sliding external osteosynthesis. Clin Orthop 1986:169-84.
69. Dehne R, Metz CW, Deffer PA, et al. Nonoperative treatment of the fractured tibia by immediate weight bearing. J Trauma 1961;1:514-35.
70. Pandey R, White SH, Kenwright J. Callus distraction in ollier's disease. Acta Orthop Scand 1995;66: 479-80.
71. Mofid MM, Inoue N, Atabey A, et al. Callus stimulation in distraction osteogenesis. Plast Reconstr Surg 2002;109:1621-9.
72. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract 2002;5:143-51.
73. Moss SD, Joganic E, Manwaring KH, et al. Transplanted demineralized bone graft in cranial reconstructive surgery. Pediatr Neurosurg 1995;23: 199-204.
74. Goodrich JT, Argamaso R, Hall CD. Split-thickness bone grafts in complex craniofacial reconstructions. Pediatr Neurosurg 1992;18:195-201.
75. Shenaq SM. Reconstruction of complex cranial and craniofacial defects utilizing iliac crest-internal oblique microsurgical free flap. Microsurgery 1988; 9:154-8.
76. Marchac D. Split-rib grafts in craniofacial surgery. Plast Reconstr Surg 1982;69:566-7.
77. Bruens ML, Pieterman H, de Wijn JR, et al. Porous polymethylmethacrylate as bone substitute in the craniofacial area. J Craniofac Surg 2003;14:63-8.
78. Dean D, Topham NS, Rimnac C, et al. Osseointegration of preformed polymethylmethacrylate craniofacial prostheses coated with bone marrow-impregnated poly (dl-lactic-co-glycolic acid) foam. Plast Reconstr Surg 1999;104:705-12.
79. Nicholson JW. Glass-ionomers in medicine and dentistry. Proc Inst Mech Eng [H] 1998;212:121-6.
80. Rah DK. Art of replacing craniofacial bone defects. Yonsei Med J 2000;41:756-65.
81. Hassler W, Zentner J. Radical osteoclastic craniectomy in sagittal synostosis. Neurosurgery 1990;27:539.
82. Sirola K. Regeneration of defects in the calvaria. Ann Med Exp Biol Fenn 1960;38:1-87.
83. Mulliken JB, Glowacki J. Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg 1980;65:553-60.
84. Bostrom R, Mikos A. Tissue engineering of bone. In: Atala A, Mooney DJ, Vacanti JP, et al, editors. Synthetic biodegradable polymer scaffolds. Boston: Birkhauser; 1997. p. 215-34.
85. Saadeh PB, Khosla RK, Mehrara BJ, et al. Repair of a critical size defect in the rat mandible using allogenic type i collagen. J Craniofac Surg 2001;12:573-9.
86. Seol YJ, Lee JY, Park YJ, et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 2004;26:1037-41.
87. Bumgardner JD, Wiser R, Gerard PD, et al. Chitosan: potential use as a bioactive coating for orthopaedic and craniofacial/dental implants. J Biomater Sci Polym Ed 2003;14:423-38.
88. Solchaga LA, Gao J, Dennis JE, et al. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 2002;8:333-47.
89. Cho BC, Kim JY, Lee JH, et al. The bone regenerative effect of chitosan microsphere-encapsulated growth hormone on bony consolidation in mandibular distraction osteogenesis in a dog model. J Craniofac Surg 2004;15:299-311.
90. Zhang Y, Zhang M. Synthesis and characterization of macroporous chitosan/calcium phosphate composite scaffolds for tissue engineering. J Biomed Mater Res 2001;55:304-12.
91. LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop 2002:81-98.
92. Osborn JF, Newesely H. The material science of calcium phosphate ceramics. Biomaterials 1980;1: 108-11.
93. Blokhuis TJ, Termaat MF, den Boer FC, et al. Properties of calcium phosphate ceramics in relation to their in vivo behavior. J Trauma 2000;48:179-86.
94. Albee FH. Studies in bone growth: triple cap as a stimulus to osteogenesis. Ann Surg 1920;71:32-6.
95. Groot KD. Bioceramics of calcium phosphate. Boca Raton (FL): CRC Press; 1983.
96. Ducheyne P. Bioceramics: material characteristics versus in vivo behavior. J Biomed Mater Res 1987; 21:219-36.
97. Yaszemski MJ, Payne RG, Hayes WC, et al. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996;17:175-85.
98. Schliephake H, Gruber R, Dard M, et al. Repair of calvarial defects in rats by prefabricated hydroxyapatite cement implants. J Biomed Mater Res 2004; 69A:382-90.
99. Boo JS, Yamada Y, Okazaki Y, et al. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg 2002;13: 231-9.
100. Harris CT, Cooper LF. Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J Biomed Mater Res 2004;68A:747-55.
101. Ramay HR, Zhang M. Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering. Biomaterials 2004; 25:5171-80.
102. Xu HH, Simon Jr CG. Self-hardening calcium phosphate composite scaffold for bone tissue engineering. J Orthop Res 2004;22:535-43.
103. Xu HH, Quinn JB, Takagi S, et al. Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering. Biomaterials 2004;25:1029-37.
104. Lanza RP, Langer RS, Vacanti J. Principles of tissue engineering. 2nd edition. San Diego (CA): Academic Press; 2000.
105. Behravesh E, Yasko AW, Engel PS, et al. Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop 1999:8118-29.
106. Ishaug SL, Crane GM, Miller MJ, et al. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
107. Ishaug SL, Yaszemski MJ, Bizios R, et al. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 1994;28:1445-53.
108. Barrere F, van der Valk CM, Dalmeijer RA, et al. Osteogenecity of octacalcium phosphate coatings applied on porous metal implants. J Biomed Mater Res 2003;66A:779-88.
109. Barrere F, Layrolle P, Van Blitterswijk C, et al. Biomimetic coatings on titanium: a crystal growth study of octacalcium phosphate. J Mater Sci Mater Med 2001;6:529-34.
110. Kokubo T, Kim HM, Kawashita M. Novel bioactive materials with different mechanical properties. Biomaterials 2003;24:2161-75.
111. Chou YF, Chiou WA, Xu Y, et al. The effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials 2004;25:5323-31.
112. Chou YF, Huan W, Dunn JC, et al. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials 2005; 26(3):285-95.
113. Yang Y, Magnay J, Cooling L, et al. Effects of substrate characteristics on bone cell response to the mechanical environment. Med Biol Eng Comput 2004; 42:22-9.
114. Bahadur G. The moral status of the embryo: the human embryo in the UK Human Fertilisation and Embryology (Research Purposes) Regulation 2001 debate. Reprod Biomed Online 2003;7:12-6.
115. Chin JJ. Ethical issues in stem cell research. Med J Malaysia 2003;58(Suppl A):111-8.
116. Weissman IL. Stem cells-scientific, medical, and political issues. N Engl J Med 2002;346:1576-9.
117. Dixon N. Cancer scare hits gene cures: a second major setback for medicine's most pioneering treatment has split the scientific community Could a moratorium do more harm than good? New Sci 2002; 176:4-5.
118. Grilley BJ, Gee AP. Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility. Cytotherapy 2003;5:197-207.
119. Smith L, Byers JF. Gene therapy in the post-gelsinger era. JONAS Healthe Law Ethics Regul 2002;4: 104-10.
120. Verma IM. A voluntary moratorium? Mol Ther 2003; 7:141.
121. Forbes SJ, Poulsom R, Wright NA. Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 2002;9:625-30.
122. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
123. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-95.
124. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116:639-48.
125. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-9.
126. Rickard DJ, Sullivan TA, Shenker BJ, et al. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and bmp-2. Dev Biol 1994;161:218-28.
127. Long MW, Robinson JA, Ashcraft EA, et al. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 1995;95:881-7.
128. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 1999;48:913-27.
129. Dennis JE, Haynesworth SE, Young RG, et al. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1992;1:23-32.
130. Abukawa H, Terai H, Hannouche D, et al. Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg 2003;61:94-100.
131. Cicuttini FM, Welch K, Boyd AW. Characterization of cd34 + hla-dr-cd38 + and cd34 + hla-dr-cd38-progenitor cells from human umbilical cord blood. Growth Factors 1994;10:127-34.
132. Banfi A, Muraglia A, Dozin B, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000;28:707-15.
133. Bergman RJ, Gazit D, Kahn AJ, et al. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 1996;11:568-77.
134. Stenderup K, Justesen J, Clausen C, et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-26.
135. Stenderup K, Rosada C, Justesen J, et al. Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology 2004;5:107-18.
136. Mendes SC, Tibbe JM, Veenhof M, et al. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 2002;8:911-20.
137. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001;82:583-90.
138. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28.
139. Cousin B, Andre M, Arnaud E, et al. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun 2003; 301:1016-22.
140. Huang JI, Beanes SR, Zhu M, et al. Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. Plast Reconstr Surg 2002;109: 1033-41.
141. Gimble JM, Guilak F. Differentiation potential of adipose derived adult stem (adas) cells. Curr Top Dev Biol 2003;58:137-60.
142. Shi Y, Nacamuli RP, Salim A, et al. The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg, Accepted for publication.
143. Ashjian PH, Elbarbary AS, Edmonds B, et al. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 2003;111:1922-31.
144. Lee JA, Parrett BM, Conejero JA, et al. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 2003;50:610-7.
145. Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004;10:371-80.
146. Dragoo JL, Choi JY, Lieberman JR, et al. Bone induction by bmp-2 transduced stem cells derived from human fat. J Orthop Res 2003;21:622-9.
147. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560-7.
148. Cao Y, Vacanti JP, Paige KT, et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 1997;100:297-302.
149. Barron V, Lyons E, Stenson-Cox C, et al. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 2003;31:1017-30.
150. Fauza DO, Marier JJ, Koka R, et al. Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg 2001;36:146-51.
151. Sodian R, Lemke T, Pritsche C, et al. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng 2002;8:863-70.
152. Gabouev AI, Schultheiss D, Mertsching H, et al. In vitro construction of urinary bladder wall using porcine primary cells reseeded on acellularized bladder matrix and small intestinal submucosa. Int J Artif Organs 2003;26:935-42.